Targeting <i>FGFR3</i> alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Sumanta K. Pal Diederik M. Somford |
| Publication date | July 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |